- Home
- TSHA vs OMDA Comparison
TSHA vs OMDA Comparison
Compare TSHA & OMDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TSHA
- OMDA
- Stock Information
- Founded
- TSHA 2019
- OMDA 2011
- Country
- TSHA United States
- OMDA United States
- Employees
- TSHA N/A
- OMDA N/A
- Industry
- TSHA Biotechnology: Pharmaceutical Preparations
- OMDA Medical/Nursing Services
- Sector
- TSHA Health Care
- OMDA Health Care
- Exchange
- TSHA Nasdaq
- OMDA Nasdaq
- Market Cap
- TSHA 1.2B
- OMDA 1.3B
- IPO Year
- TSHA 2020
- OMDA 2025
- Fundamental
- Price
- TSHA $4.87
- OMDA $18.21
- Analyst Decision
- TSHA Strong Buy
- OMDA Strong Buy
- Analyst Count
- TSHA 9
- OMDA 9
- Target Price
- TSHA $10.22
- OMDA $26.44
- AVG Volume (30 Days)
- TSHA 3.9M
- OMDA 686.0K
- Earning Date
- TSHA 11-04-2025
- OMDA 11-06-2025
- Dividend Yield
- TSHA N/A
- OMDA N/A
- EPS Growth
- TSHA N/A
- OMDA N/A
- EPS
- TSHA N/A
- OMDA N/A
- Revenue
- TSHA $6,310,000.00
- OMDA $232,342,000.00
- Revenue This Year
- TSHA N/A
- OMDA $43.42
- Revenue Next Year
- TSHA N/A
- OMDA $20.01
- P/E Ratio
- TSHA N/A
- OMDA N/A
- Revenue Growth
- TSHA N/A
- OMDA 89.23
- 52 Week Low
- TSHA $1.05
- OMDA $14.14
- 52 Week High
- TSHA $5.51
- OMDA $28.40
- Technical
- Relative Strength Index (RSI)
- TSHA 62.34
- OMDA N/A
- Support Level
- TSHA $3.92
- OMDA N/A
- Resistance Level
- TSHA $4.34
- OMDA N/A
- Average True Range (ATR)
- TSHA 0.30
- OMDA 0.00
- MACD
- TSHA 0.06
- OMDA 0.00
- Stochastic Oscillator
- TSHA 98.33
- OMDA 0.00
About TSHA Taysha Gene Therapies Inc.
Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease. It is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the CNS in both rare and large patient populations. The company develops and commercializes transformative gene therapy treatments. Its product pipeline includes, TSHA-102 which is a is a self-complementary intrathecally delivered AAV9 gene transfer therapy in clinical evaluation for Rett syndrome.
About OMDA Omada Health Inc. Common Stock
Omada Health Inc empowers individuals to make lasting health changes through personalized, virtual care between doctor's visits. The integrated platform of the company supports members with cardiometabolic conditions like prediabetes, diabetes, hypertension, musculoskeletal issues, and behavioral health needs. The company's specialized care tracks also assist members using GLP-1 medications. The Company delivers measurable health outcomes and value for employers, health plans, health systems, and pharmacy benefit managers.